A Comparative study to evaluate the efficacy of Yashtyahwa Niruha Basti and Bodhi Vriksha Kashaya in Vatarakta w.s.r. to Gout
Trial Snapshot
- Phase
- Phase 2/3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Relief from essential symptoms like pain, swelling and tenderness
Study Overview
Brief Summary
clinical study:
patients of vatarakta will be selected from the OPD and IPD of the Government P.G. Ayurveda college and hospital, Varanasi.
1.Inclusion criteria : patients with serum uric acid more than 7mg/dl in males and more than 6 mg/dl in females.
2.Exclusion criteria: patients with serum uric acid more than 11.6mg/dl in males and 10.3 mg/dl in females.
- groups:
Group A : 30 patients will be given tila taila anuvasana basti and yashtyahwa niruha basti alternately for 16 days( kala krama method).
Group B: 30 patients will be given bodhi vriksha kashaya 50ml orally with madhu anupana in empty stomach twice a day for 16 days.
-
assessment criteria: the study will be carried out for 30 days. the patient will be assessed on day 1 day 16th and day 30th on the basis of symptoms and uric acid level.
-
statistical analysis method: the parameters of baseline will be compared with the follow-up status for the assessment of results.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Open Label
Eligibility Criteria
- Ages
- 20.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1-The patient of vatarakta having serum uric acid more than 7mg/dl in male and more than 6 mg/dl in females.
- •2-All 3 essential symptoms with or without non essential symptomatology essential symptoms: sandhishu ruk sandhishu shyvathu sparsh ashahtvam Non essential symptomatology :angagrah sandhisu kandu sandhisu daha shyavaraktatva-twakbahotamra.
Exclusion Criteria
- •1-Patients having serum uric acid more than 11.6mg/dl in males and more than 10.3 mg/dl in females.
- •2-The patients suffering from uncontrolled diabetes, uncontrolled thyroid disorder and other systemic disorders.
- •3-Pregnancy and lactating female patients.
- •4-The patients having symptoms of vatrakta upadrava;hikka,murcha,moha,visarpa,manskoth,angulivakrata 5-Chronic joint deformity, marked dysfunction, discharging tophi.
- •6-Known cases of SLE, renal disease, hepatic disease, patients on ATT , cardiac patients on low dose aspirin, RA, OA, Psoriatic arthritis.
Outcomes
Primary Outcomes
Relief from essential symptoms like pain, swelling and tenderness
Time Frame: 16 days
Secondary Outcomes
- Decreased serum uric acid level.(16 days)